Diabetes Mellitus
📧 Sign up to get email alerts when something new happens for Diabetes Mellitus.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2013-02-21FDA Approved: HUMULIN N — Supplemental Application (Eli Lilly and Company)
FDA approved a supplemental application for HUMULIN N (insulin human) from Eli Lilly and Company.
-
FDA approval · 2013-02-15FDA Approved: HUMALOG MIX75/25 — Supplemental Application (Eli Lilly and Company)
The FDA approved a supplemental application for HUMALOG MIX75/25 (insulin lispro) by Eli Lilly and Company. This action expands the regulato…
-
FDA approval · 2013-02-15FDA Approved: HUMALOG MIX50/50 KWIKPEN — Supplemental Application (Eli Lilly and Company)
FDA approved a supplemental application for HUMALOG MIX50/50 KWIKPEN (insulin lispro) from Eli Lilly and Company. The decision updates the m…
-
FDA approval · 2013-02-15FDA Approved: HUMULIN 70/30 — Supplemental Application (Eli Lilly and Company)
The FDA approved a supplemental application for Humulin 70/30 (insulin human) from Eli Lilly and Company.
-
FDA approval · 2013-02-07FDA Approved: NOVOLIN R — Supplemental Application (Novo Nordisk)
The FDA approved a supplemental application for NOVOLIN R (human insulin) from Novo Nordisk.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2013-01-30FDA Approved: INSULIN LISPRO — Supplemental Application (Eli Lilly and Company)
FDA approved a supplemental application for insulin lispro from Eli Lilly, updating labeling for this rapid-acting insulin analogue.
-
FDA approval · 2013-01-09FDA Approved: HUMULIN R — Supplemental Application (Eli Lilly and Company)
FDA approves a supplemental application for Humulin R (insulin human) from Eli Lilly and Company.
-
FDA approval · 2012-12-13FDA Approved: NOVOLOG — Supplemental Application (Novo Nordisk)
FDA approved a supplemental application for NovoLog (insulin aspart) submitted by Novo Nordisk.
-
FDA approval · 2012-12-13FDA Approved: INSULIN ASPART PROTAMINE AND INSULIN ASPART MIX 70/30 — Supplemental Application (Novo Nordisk Pharma, Inc.)
The FDA approved a supplemental application for Novo Nordisk’s insulin aspart protamine and insulin aspart mix 70/30.
-
FDA approval · 2012-11-28FDA Approved: NOVOLOG — Supplemental Application (Novo Nordisk)
The FDA approved a supplemental application for NovoLog (insulin aspart) from Novo Nordisk. The document notes the submission status as AP (…
-
FDA approval · 2012-11-07FDA Approved: HUMULIN R — Supplemental Application (Eli Lilly and Company)
The FDA approved a supplemental application for Humulin R (insulin human) submitted by Eli Lilly and Company.
-
EMA approval · 2012-10-19European Medicines Agency recommends approval of first higher-strength insulin for treatment of patients with diabetes mellitus in the EU
EMA recommends approval of the first higher-strength insulin to treat diabetes mellitus in the EU, expanding options for insulin therapy.
-
FDA approval · 2012-10-14FDA Approved: INSULIN LISPRO — Supplemental Application (Eli Lilly and Company)
FDA approved a supplemental application for insulin lispro from Eli Lilly, along with a diluent, updating or clarifying the labeling for use…
-
FDA approval · 2012-03-29FDA Approved: HUMULIN R — Supplemental Application (Eli Lilly and Company)
FDA approved a supplemental application for Humulin R (insulin human) from Eli Lilly and Company. The approval updates the product's regulat…
-
FDA approval · 2012-03-21FDA Approved: HUMULIN N — Supplemental Application (Eli Lilly and Company)
The FDA approved a supplemental application for Humulin N (insulin human) from Eli Lilly and Company.
-
FDA approval · 2012-02-27FDA Approved: NOVOLIN R — Supplemental Application (Novo Nordisk)
FDA granted a supplemental approval for NOVOLIN R (human insulin) from Novo Nordisk.
-
FDA approval · 2011-10-30FDA Approved: HUMULIN R — Supplemental Application (Eli Lilly and Company)
The FDA approved a supplemental application for Humulin R (insulin human) from Eli Lilly and Company.
-
FDA approval · 2011-03-25FDA Approved: HUMULIN R — Supplemental Application (Eli Lilly and Company)
The FDA approved a supplemental application for Humulin R (insulin human) from Eli Lilly and Company.
-
FDA approval · 2011-03-21FDA Approved: HUMULIN R — Supplemental Application (Eli Lilly and Company)
The FDA approved a supplemental application for HUMULIN R (insulin human) from Eli Lilly and Company.
-
FDA approval · 2010-12-27FDA Approved: NOVOLIN 70/30 — Supplemental Application (Novo Nordisk)
The FDA approved a supplemental application for NOVOLIN 70/30, a human insulin product from Novo Nordisk.
-
FDA approval · 2010-12-27FDA Approved: NOVOLIN N — Supplemental Application (Novo Nordisk)
The FDA approved a supplemental application for NOVOLIN N (human insulin) from Novo Nordisk.
-
FDA approval · 2010-06-25FDA Approved: NOVOLOG — Supplemental Application (Novo Nordisk)
FDA approves a supplemental application for NovoLog (insulin aspart) submitted by Novo Nordisk.
-
FDA approval · 2010-06-25FDA Approved: NOVOLIN N — Supplemental Application (Novo Nordisk)
The FDA approved a supplemental application for NOVOLIN N (human insulin) from Novo Nordisk.
-
FDA approval · 2010-06-25FDA Approved: NOVOLIN 70/30 — Supplemental Application (Novo Nordisk)
FDA approved a supplemental application for NOVOLIN 70/30 (human insulin) by Novo Nordisk.
-
FDA approval · 2010-06-10FDA Approved: HUMULIN N — Supplemental Application (Eli Lilly and Company)
The FDA approved a supplemental application for HUMULIN N (insulin human) filed by Eli Lilly and Company.